Brca1 Mutation Carrier Active Not Recruiting Phase 2 Trials for Platinum (DB12257)

Also known as: BRCA1 Mutation Carrier

IndicationStatusPhase
DBCOND0030677 (Brca1 Mutation Carrier)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01585805Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerTreatment
NCT02595905Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain MetastasesTreatment